{"id":"https://openalex.org/W2531794674","doi":"https://doi.org/10.1182/blood.v112.11.3597.3597","title":"High Remission Rates and Prolonged Progression Free Survival in Newly Diagnosed Patients with Mantle Cell Lymphoma Treated with R-MACLOIVAM-T","display_name":"High Remission Rates and Prolonged Progression Free Survival in Newly Diagnosed Patients with Mantle Cell Lymphoma Treated with R-MACLOIVAM-T","publication_year":2008,"publication_date":"2008-11-16","ids":{"openalex":"https://openalex.org/W2531794674","doi":"https://doi.org/10.1182/blood.v112.11.3597.3597","mag":"2531794674"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v112.11.3597.3597","doi":"https://doi.org/10.1182/blood.v112.11.3597.3597","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v112.11.3597.3597","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5065012486","display_name":"Peter J. Hosein","orcid":"https://orcid.org/0000-0001-8537-6397","observed_orcids":["https://orcid.org/0000-0001-8537-6397"]},"institutions":[{"id":"https://openalex.org/I145608581","display_name":"University of Miami","ror":"https://ror.org/02dgjyy92","country_code":"US","type":"education","lineage":["https://openalex.org/I145608581"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peter J Hosein","raw_affiliation_strings":["University of Miami Miller School of Medicine, Miami, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Miami Miller School of Medicine, Miami, FL, USA","institution_ids":["https://openalex.org/I145608581"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031420337","display_name":"Daniel Morgensztern","orcid":"https://orcid.org/0000-0003-4349-2028","observed_orcids":["https://orcid.org/0000-0003-4349-2028"]},"institutions":[{"id":"https://openalex.org/I145608581","display_name":"University of Miami","ror":"https://ror.org/02dgjyy92","country_code":"US","type":"education","lineage":["https://openalex.org/I145608581"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Daniel Morgensztern","raw_affiliation_strings":["University of Miami Miller School of Medicine, Miami, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Miami Miller School of Medicine, Miami, FL, USA","institution_ids":["https://openalex.org/I145608581"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075670801","display_name":"Francine Coleman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145608581","display_name":"University of Miami","ror":"https://ror.org/02dgjyy92","country_code":"US","type":"education","lineage":["https://openalex.org/I145608581"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Francine Coleman","raw_affiliation_strings":["University of Miami Miller School of Medicine, Miami, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Miami Miller School of Medicine, Miami, FL, USA","institution_ids":["https://openalex.org/I145608581"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109174234","display_name":"Gail R. Walker","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145608581","display_name":"University of Miami","ror":"https://ror.org/02dgjyy92","country_code":"US","type":"education","lineage":["https://openalex.org/I145608581"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Gail Walker","raw_affiliation_strings":["University of Miami Miller School of Medicine, Miami, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Miami Miller School of Medicine, Miami, FL, USA","institution_ids":["https://openalex.org/I145608581"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045116344","display_name":"Maricer P. Escal\u00f3n","orcid":"https://orcid.org/0000-0001-6454-0557","observed_orcids":["https://orcid.org/0000-0001-6454-0557"]},"institutions":[{"id":"https://openalex.org/I145608581","display_name":"University of Miami","ror":"https://ror.org/02dgjyy92","country_code":"US","type":"education","lineage":["https://openalex.org/I145608581"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maricer Escalon","raw_affiliation_strings":["University of Miami Miller School of Medicine, Miami, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Miami Miller School of Medicine, Miami, FL, USA","institution_ids":["https://openalex.org/I145608581"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060976304","display_name":"Joseph D. Rosenblatt","orcid":"https://orcid.org/0000-0003-0798-0403","observed_orcids":["https://orcid.org/0000-0003-0798-0403"]},"institutions":[{"id":"https://openalex.org/I145608581","display_name":"University of Miami","ror":"https://ror.org/02dgjyy92","country_code":"US","type":"education","lineage":["https://openalex.org/I145608581"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph Rosenblatt","raw_affiliation_strings":["University of Miami Miller School of Medicine, Miami, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Miami Miller School of Medicine, Miami, FL, USA","institution_ids":["https://openalex.org/I145608581"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5049069261","display_name":"Izidore S. Lossos","orcid":"https://orcid.org/0000-0002-9346-9013","observed_orcids":["https://orcid.org/0000-0002-9346-9013"]},"institutions":[{"id":"https://openalex.org/I145608581","display_name":"University of Miami","ror":"https://ror.org/02dgjyy92","country_code":"US","type":"education","lineage":["https://openalex.org/I145608581"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Izidore S Lossos","raw_affiliation_strings":["University of Miami Miller School of Medicine, Miami, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Miami Miller School of Medicine, Miami, FL, USA","institution_ids":["https://openalex.org/I145608581"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5031420337","https://openalex.org/A5075670801","https://openalex.org/A5109174234"],"corresponding_institution_ids":["https://openalex.org/I145608581"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.4742,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.72407038,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"112","issue":"11","first_page":"3597","last_page":"3597"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10685","display_name":"Viral-associated cancers and disorders","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12212","display_name":"CNS Lymphoma Diagnosis and Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mantle-cell-lymphoma","display_name":"mantle cell lymphoma","score":0.9950000047683716},{"id":"https://openalex.org/keywords/high-dose-chemotherapy","display_name":"high-dose chemotherapy","score":0.6949999928474426},{"id":"https://openalex.org/keywords/autologous-stem-cell-transplantation","display_name":"autologous stem cell transplantation","score":0.9169999957084656},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.7590000033378601},{"id":"https://openalex.org/keywords/remission-rate","display_name":"remission rate","score":0.6119999885559082},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.7390000224113464},{"id":"https://openalex.org/keywords/cytarabine","display_name":"cytarabine","score":0.7300000190734863},{"id":"https://openalex.org/keywords/etoposide","display_name":"etoposide","score":0.7789999842643738},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.6930000185966492},{"id":"https://openalex.org/keywords/methotrexate","display_name":"methotrexate","score":0.7879999876022339},{"id":"https://openalex.org/keywords/cyclophosphamide","display_name":"cyclophosphamide","score":0.7310000061988831},{"id":"https://openalex.org/keywords/granulocyte-colony-stimulating-factor","display_name":"granulocyte colony-stimulating factor","score":0.49799999594688416},{"id":"https://openalex.org/keywords/newly-diagnosed-lymphoma","display_name":"newly diagnosed lymphoma","score":0.8669999837875366}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8540284633636475},{"id":"https://openalex.org/C2777525834","wikidata":"https://www.wikidata.org/wiki/Q268713","display_name":"Mantle cell lymphoma","level":3,"score":0.7570154666900635},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6237305402755737},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.6016175746917725},{"id":"https://openalex.org/C2779429289","wikidata":"https://www.wikidata.org/wiki/Q408977","display_name":"Vincristine","level":4,"score":0.5907611846923828},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5671419501304626},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.5290094017982483},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.5024175643920898},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.4877474904060364},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.44835740327835083},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.3698572516441345},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2975899577140808}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v112.11.3597.3597","doi":"https://doi.org/10.1182/blood.v112.11.3597.3597","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v112.11.3597.3597","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8100000023841858}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2552672333","https://openalex.org/W2984708575","https://openalex.org/W2561487623","https://openalex.org/W1999921844","https://openalex.org/W1949456147","https://openalex.org/W3135982718","https://openalex.org/W2591110429","https://openalex.org/W2137182804","https://openalex.org/W2622297972","https://openalex.org/W7217202030"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Mantle":[2],"cell":[3,538],"lymphoma":[4,13],"(MCL)":[5],"is":[6,53,509,714],"an":[7,36],"unfavorable":[8],"subtype":[9],"of":[10,25,81,89,101,108,127,145,181,340,439,468,493,502,561,570,582,590,621,643,659,673,683,701],"B-cell":[11],"non-Hodgkin":[12],"characterized":[14],"by":[15,93,156,232,240,331],"median":[16,21,491,657,662],"progression-free":[17],"survival":[18,23,119],"(PFS)":[19],"and":[20,28,35,79,142,164,204,216,278,286,305,314,327,357,374,401,419,428,449,453,473,481,528,554,559,564,568,613,632,647,650,664,685,691],"overall":[22,640],"(OS)":[24],"only":[26],"1.5":[27,211,288],"3\u20134":[29,551,611,623],"years":[30,384],"respectively.":[31,573],"Although":[32],"high-dose":[33],"therapy":[34,341],"autotransplant":[37],"may":[38],"prolong":[39],"OS,":[40],"it":[41],"does":[42],"not":[43,667],"result":[44],"in":[45,71,174,309,355,359,399,404,444,531,556,565,578,605,617,637],"a":[46,54,66,82,87,90,109,124,499,638,651,656],"long-term":[47],"disease":[48,394],"free":[49,118,489],"survival.":[50,633],"Therefore,":[51],"there":[52],"need":[55],"for":[56,60,114,372,378,630,687],"novel":[57,83],"therapeutic":[58],"approaches":[59],"this":[61,705],"entity.":[62],"Methods:":[63],"We":[64],"conducted":[65],"single-arm":[67],"phase":[68],"II":[69],"study":[70,99],"subjects":[72,122,171,324,365,369,388,424,434,446,464,477,607,619],"with":[73,258,293,395,677,692],"newly-diagnosed":[74],"MCL":[75,128,347],"to":[76,167,219,312,408,609,704],"assess":[77],"efficacy":[78],"safety":[80],"intensive":[84],"regimen":[85],"R-MACLO-IVAM-T,":[86],"modification":[88],"protocol":[91],"designed":[92],"Magrath":[94],"et":[95],"al":[96],"(JCO1996;14:925).":[97],"The":[98,599,669,699],"size":[100],"22":[102,364],"patients":[103,513],"was":[104,154,246,254,260,382,442,603],"based":[105],"on":[106,187,194,201,207,213,225,248,275,283,290,523],"precision":[107],"two-sided":[110],"95%":[111],"confidence":[112],"interval":[113],"the":[115,175,252,338,362,458,462,505,529],"18-month":[116],"progression":[117],"rate.":[120,654],"Eligible":[121],"had":[123,389,425,430],"confirmed":[125],"diagnosis":[126],"using":[129],"WHO":[130],"criteria,":[131],"age":[132,381],"18\u201375":[133],"years,":[134],"ECOG":[135],"PS":[136],"\u2264":[137],"2,":[138,279,302],"adequate":[139],"organ":[140],"function":[141],"no":[143],"history":[144],"HIV":[146],"or":[147,349,615],"prior":[148],"cancer.":[149],"Lymphoma":[150],"extent":[151],"at":[152,337,390,479,533],"presentation":[153],"assessed":[155,330],"standard":[157,332],"staging":[158],"procedures":[159],"as":[160,162],"well":[161],"esophagogastroduodenoscopy":[163],"colonoscopy.":[165],"Prior":[166],"initiating":[168],"thalidomide":[169,343,600,702],"maintenance,":[170],"were":[172,307,325,329,366,370,376,517,549,575,584,666],"enrolled":[173],"STEPS\u00ae":[176],"program.":[177],"Cycle":[178],"1":[179,203,215,229,277,313,520,525],"consisted":[180],"R-MACLO:":[182],"rituximab":[183,262],"375":[184,263],"mg/m2":[185,192,199,212,264,282],"IV":[186,193,200,224,235,265,271],"day":[188,195,202,226,249,266,526],"1,":[189,196,267],"doxorubicin":[190],"45":[191],"cyclophosphamide":[197],"800":[198],"200":[205,344],"mg/m2/day":[206],"days":[208,214,276,284,291,296],"2\u20135,":[209],"vincristine":[210],"8":[217,527,618],"capped":[218],"2mg,":[220],"methotrexate":[221],"1.2":[222],"g/m2":[223,234,270,289],"10":[227],"over":[228,236],"hour":[230],"followed":[231,239],"5.52":[233],"23":[237],"hours":[238,243,274],"leucovorin":[241],"36":[242],"later.":[244],"G-CSF":[245],"begun":[247],"13.":[250],"When":[251],"ANC":[253,298,319],">1.5\u00d7109/L,":[255],"cycle":[256,301,322,524],"2":[257,269,413,429,445,448,466],"R-IVAM":[259,571,586],"begun:":[261],"cytarabine":[268],"every":[272],"12":[273,581],"etoposide,":[280],"60":[281],"1\u20135":[285,292],"ifosfamide":[287],"mesna.":[294],"Fourteen":[295],"after":[297,318,447,490,544,585,597],"recovery":[299,320],"from":[300,321,521,536],"cycles":[303,438,451,467,563,572],"3":[304,393,416,450],"4":[306,420,437],"given":[308],"identical":[310],"fashion":[311],"2.":[315],"Four":[316],"weeks":[317],"4,":[323],"re-staged":[326],"responses":[328],"criteria.":[333],"Subjects":[334],"achieving":[335],"CR":[336,472,532,646],"end":[339],"received":[342],"mg/day":[345],"until":[346],"relapse":[348,488,507,631,653],"intolerable":[350],"toxicity.":[351],"Results:":[352],"Accrual":[353],"started":[354],"4/2004":[356],"ended":[358],"3/2008":[360],"when":[361],"planned":[363],"enrolled.":[367],"All":[368,387],"evaluable":[371,377],"toxicity":[373,595],"21":[375,463],"response.":[379],"Median":[380],"56.5":[383],"(range":[385,496],"39\u201373).":[386],"least":[391],"stage":[392],"bone":[396,694],"marrow":[397,695],"involvement":[398,403],"19":[400,486,542],"gastrointestinal":[402],"10.":[405],"Distribution":[406],"according":[407],"IPI:":[409],"0\u20131":[410],"factor,":[411],"3;":[412],"factors,":[414,417,421],"8;":[415,418],"3.":[422],"Twenty":[423],"diffuse":[426],"variant":[427],"blastic":[431],"variant.":[432],"Nineteen":[433],"completed":[435],"all":[436],"therapy;":[440],"treatment":[441],"stopped":[443,616],"respectively,":[452,484],"one":[454,474],"subject":[455],"died":[456],"during":[457],"first":[459],"cycle.":[460],"Of":[461],"completing":[465],"therapy,":[469],"20":[470],"achieved":[471],"PR.":[475],"Two":[476],"relapsed":[478],"9":[480],"33":[482],"months":[483,495,535,543],"while":[485],"remain":[487,627],"follow-up":[492,501,629,658],"25":[494,660],"5\u201351).":[497],"With":[498],"total":[500],"545":[503],"months,":[504,661],"estimated":[506],"rate":[508,642],"4.4":[510],"per":[511,514],"100":[512],"year.":[515],"There":[516,574],"two":[518],"deaths:":[519],"sepsis":[522],"other":[530],"38":[534],"non-small":[537],"lung":[539],"cancer":[540],"diagnosed":[541],"MCL.":[545],"Common":[546],"severe":[547],"toxicities":[548],"grade":[550,592,610,622],"neutropenia,":[552],"thrombocytopenia":[553],"anemia":[555],"33%,":[557],"19%":[558],"17%":[560],"R-MACLO":[562],"50%,":[566],"88%":[567],"68%":[569],"14":[576],"bacteremias":[577],"82":[579],"cycles,":[580],"which":[583],"therapy.":[587],"Six":[588],"episodes":[589],"reversible":[591],"1\u20132":[593],"renal":[594],"occurred":[596],"methotrexate.":[598],"maintenance":[601,703],"dose":[602],"reduced":[604,614],"6":[606],"due":[608],"neutropenia":[612],"because":[620],"peripheral":[624],"neuropathy.":[625],"Patients":[626],"under":[628],"Conclusions:":[634],"R-MACLO-IVAM-T":[635],"results":[636],"high":[639],"response":[641],"100%":[644],"(95%":[645],"5%":[648],"PR)":[649],"low":[652],"At":[655],"PFS":[663,672,682],"OS":[665],"reached.":[668],"2-year":[670,680],"actuarial":[671,681],"94%":[674],"compares":[675],"favorably":[676],"previously":[678],"reported":[679],"40%":[684],"67%":[686],"CHOP-like":[688],"regimens":[689],"without":[690],"upfront":[693],"transplantation":[696],"(Blood2005;105:":[697],"2677).":[698],"contribution":[700],"outcome":[706],"requires":[707],"additional":[708],"study.":[709],"A":[710],"multicenter":[711],"clinical":[712],"trial":[713],"suggested.":[715]},"counts_by_year":[],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2016-10-21T00:00:00"}